Interaction Between Celecoxib and Cisplatin is Dependent on The p53 Status in Human NSCLC Cell Lines

被引：0
|
作者：
Jiang, M. [1 ]
Li, W. [1 ]
Ma, L. [1 ]
Zhang, L. [1 ]
Tan, J. [1 ]
Zheng, S. [1 ]
Liu, Y. [1 ]
机构：
[1] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
lung cancer; p53; celecoxib;
D O I：
10.1016/j.jtho.2018.08.695
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-14
引用
收藏
页码：S517 / S517
页数：1
相关论文
共 50 条
  • [11] Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin
    Pagliaro, LC
    Keyhani, A
    Liu, BS
    Perrotte, P
    Wilson, D
    Dinney, CP
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (06) : 456 - 462
  • [12] The role of functional p53 in cisplatin chemosensitivity in a panel of human ovarian cancer cell lines.
    Walton, MI
    Koshy, P
    Medlow, CJ
    Sharp, S
    Kelland, LR
    Sharp, S
    Titley, J
    BRITISH JOURNAL OF CANCER, 1998, 78 : 19 - 19
  • [13] Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines
    Oka, H
    Ikeda, K
    Yoshimura, H
    Ohuchida, A
    Honma, M
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2006, 606 (1-2) : 52 - 60
  • [14] Inverse correlation between RER(+) status and p53 mutation in colorectal cancer cell lines
    Cottu, PH
    Muzeau, F
    Estreicher, A
    Flejou, JF
    Iggo, R
    Thomas, G
    Hamelin, R
    ONCOGENE, 1996, 13 (12) : 2727 - 2730
  • [15] p53 status correlates with the sensitivity to PM00104 in human cancer cell lines
    Martinez-Leal, Juan
    Moneo, Victoria
    de Castro, Beatriz
    Cascajares, Sofia
    Cuevas, Carmen
    Garcia-Fernandez, Luis
    Galmarini, Carlos
    CANCER RESEARCH, 2009, 69
  • [16] p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel
    Debernardis, D
    Sire, EG
    DeFeudis, P
    Vikhanskaya, F
    Valenti, M
    Russo, P
    Parodi, S
    DIncalci, M
    Broggini, M
    CANCER RESEARCH, 1997, 57 (05) : 870 - 874
  • [17] Telomeric length in individuals and cell lines with altered p53 status
    Kruk, PA
    Bohr, VA
    RADIATION ONCOLOGY INVESTIGATIONS, 1999, 7 (01): : 13 - 21
  • [18] The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines
    Choi, Hyeong Sim
    Kim, Young-Kyun
    Yun, Pil-Young
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (01) : 617 - 625
  • [19] The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines
    Hyeong Sim Choi
    Young-Kyun Kim
    Pil-Young Yun
    Molecular Biology Reports, 2019, 46 : 617 - 625
  • [20] The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines
    Jo, Deuk-Won
    Kim, Young-Kyun
    Yun, Pil-Young
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2016, 42 (06) : 337 - 344
12345